DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydroxyurea (Hydroxyurea) - Acute Myeloid Leukaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Myeloid Leukaemia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydroxyurea where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydroxyurea side effects in 41 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06

Patient: 41 year old male

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydroxyurea



Possible Hydroxyurea side effects in 81 year old female

Reported by a physician from United States on 2012-06-12

Patient: 81 year old female, weighing 95.7 kg (210.5 pounds)

Reactions: Bacteraemia, Lung Infection, Acute Myeloid Leukaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydroxyurea
    Administration route: Oral
    End date: 2012-01-18

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2012-01-18
    End date: 2012-01-24

Gemtuzumab
    Dosage: 3 milligram/sq. meter
    Start date: 2012-01-18
    End date: 2012-01-25

Other drugs received by patient: Losartan; Coreg



Possible Hydroxyurea side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01

Patient:

Reactions: Death, Acute Myeloid Leukaemia, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Azacitidine
    Dosage: 75 milligram/sq. meter

Gemtuzumab Ozogamicin
    Dosage: 3 milligram/sq. meter

Hydroxyurea
    Dosage: 1500 milligram



Possible Hydroxyurea side effects in

Reported by a individual with unspecified qualification from United States on 2012-05-10

Patient:

Reactions: Death, Respiratory Failure, Subarachnoid Haemorrhage, Acute Myeloid Leukaemia, Sepsis, Myelodysplastic Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydroxyurea



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-04-02

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-03-25

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01

Patient: 33 year old male

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Idarubicin HCL
    Indication: Acute Myeloid Leukaemia

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia

Fludarabine Phosphate
    Indication: Acute Myeloid Leukaemia

Hydroxyurea
    Dosage: started as 9mg/kg 4 yrs later received 18mg/kg
    Indication: Sickle Cell Anaemia

Cytarabine
    Indication: Acute Myeloid Leukaemia



Possible Hydroxyurea side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-01-20

Patient: 56 year old male

Reactions: Therapeutic Response Decreased, Acute Myeloid Leukaemia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Daunorubicin HCL

Azacitidine

Nilotinib

Interferon Alfa

Imatinib Mesylate

Hydroxyurea

Dasatinib

Arabinoside
    Dosage: 3 + 7 induction regimen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017